Table 2.
Patients on warfarin treatment in a registered population of 75146. Treatment diagnosis, prevalence and incidence, presented as number of patients and percentage.
| Treatment diagnosis | Number of patients (n) | Mean age | Percentage of women (%) | Percentage of the study group (%) (n = 507) | Prevalence (%) | Incidence (%) |
| Chronic atrial fibrillation | 211 | 73.8 | 42.2 2 | 41.6 | 0.28 | 0.07 |
| Cerebrovascular disease | 96 | 74.5 | 47.9 | 18.9 | 0.13 | 0.02 |
| Deep venous thrombosis | 96 | 69.4 | 42.1 | 18.9 | 0.13 | 0.05 |
| Prosthetic valve | 89 | 70.1 | 42.7 | 17.6 | 0.12 | 0.01 |
| Pulmonary embolism | 65 | 72.4 | 53.9 | 12.8 | 0.09 | 0.01 |
| Peripheral artery disease | 14 | 80.8 | 50.0 | 2.8 | 0.02 | 0 |
| Cardiac infarction | 10 | 75.4 | 60.0 | 2.0 | 0.01 | 0.01 |
| Other indications | 31 | 71.6 | 45.2 | 6.1 | 0.04 | 0 |
| Any diagnosis (all patients) | 507 1 | 71.9 | 44.4 | 100 1 | 0.67 | 0.17 |
1 not a sum, as 105 patients had more than one treatment diagnosis 2 significantly more men (p = 0.02) 3 significantly more men (p = 0.01)